Katia Piñol Torres, our President and Patricia Lacruz. Directora General de Cartera Común de Servicios del Sistema Nacional de Salud y Farmacia del Ministerio de Sanidad at the opening of the course. Nice speakers and more tan 180 attendees.
Royal Decree 957/2020 As of 2 January 2021, observational studies of medicinal products for human use (‘OSM’) are to be regulated in Spain by Royal Decree 957/2020, which repeals the previously applicable Order SAS/3470/2009. The main purpose of Royal Decree 957/2020 is to simplify current procedures in this area and, above all, to focus administrative […]
Section One. Current Affairs Medicine in the courts in 2020. Jordi Faus, Xavier Moliner, Eduard Rodellar, Santiago Tomás, Anna Gerbolés, Lluís Alcover, Laura Marquès, Juan Martínez, and Joan Carles Bailach Data protection in the COVID-19 pandemic (Part II). Jesús Rubí Navarrete AEPD [Spanish Data Protection Agency]: Digital Pact for the Protection of Individuals: A commitment […]
There is an ongoing debate about certain national and international policy initiatives concerning the mandatory licensing of COVID-19 vaccine patents and we see the need to clarify certain concepts. In the event of mandatory licensing, it is more than likely that the necessary manufacturing capacity, production conditions and health guarantees would not be met. Indeed, […]
As we all know, on 1 January 2021 the new version of the Code of Practice for the Pharmaceutical Industry (the ‘new Code’ or, simply, the ‘Code’) came into force. As well as incorporating the amendments introduced in June 2019 to the Code of Practice of the European Federation of Pharmaceutical Industries and Associations (EFPIA), […]
In light of the current COVID-19 health crisis, it is an apt moment to highlight the importance of intellectual property. Intellectual and industrial property, among others, allow us to turn ideas into concrete projects that create value, wealth, jobs, and cover unmet medical needs. Above all, intellectual property serves as a basis for societal progress […]
Interruption of supply or the withdrawal of medicines from the market and competition rules. Henar González Durántez y Pilar Carrasco del Olmo 2021 versión of Pharmaceutical Industry Code of Best Practices. Teresa Paz-Ares Rodríguez, Beatriz Cocina Arrieta y Nuria Porxas Roig Regulatory framework aplicable to observational studies with medicines for human use foreseen […]
Recent investigations of the pharmaceutical sector by the competition authorities demonstrate a focus on examining a number of actions that could entail an interruption of supply or even the withdrawal of medicinal products from the market by pharmaceutical companies. Specifically, in the field of pharmaceutical law, the competition authorities have devoted particular attention to two […]
On 19 January CEFI organised a seminar to deepen our understanding of vaccines in times of pandemic. Interest in the debate, reflected in the number of registrations (298) and the quality of the speakers, most of whom are at the forefront of work to provide a vaccine for the current health crisis, ensured the session […]
Fascinating debate on vaccines with 266 registered participants and fantastic presentations by the speakers.
On 19 January 2021, CEFI will hold the online conference entitled Deepening our understanding of vaccines in times of pandemic. Registration is free of charge. Programme and registration
Two new issues of the journal published by CEFI are available: Cuadernos de Derecho Farmacéutico issue 75 (October-December 2020). Comunicaciones en Propiedad Industrial y Derecho de la Competencia issue 91 (September-December 2020).
